HB Therapeutics Inc.

Indianapolis, IN

UEI
ELJFQZFNLS48
CAGE
7HP29
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1800 N Capitol Ave e504, Indianapolis, IN 46202, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer R44CA265547 National Cancer Institute (NIH) $3,018,702
Development of small molecule SUMO1 inhibitors for treatment of glioblastoma R43CA224461 National Cancer Institute (NIH) $300,000

Quick answers

Is HB Therapeutics Inc. registered in SAM.gov?

Yes. HB Therapeutics Inc.'s SAM.gov registration is active through November 6, 2026.

What is HB Therapeutics Inc.'s most recent federal award?

HB Therapeutics Inc.'s most recent federal grant award is Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer (R44CA265547), from National Cancer Institute (NIH), on July 1, 2022.

On GovTribe

See HB Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login